We have previously described the development of cloning vectors for the production of OprI-based outer membrane fusion proteins in E. coli (Cornelis et al., 1996) and now describe the construction of a new vector, containing a lacI(q) gene, resulting in tight repression of the promotor and allowing its use in other Gram (-) bacteria. The new pVUB3 expression vector encodes a truncated but active LacI(q)(341) repressor which binds to the single operator in the vector. A high repression of the trc promotor was observed, resulting in a very low basal leakage of expression and very high production levels of OprI or derivatives after IPTG induction in E. coli. Bacterial viability was not affected under uninduced conditions, but the number of viable cell counts decreased after production of large amounts of the outer membrane-bound OprI lipoprotein and its derivatives, both in E. coli and Salmonella typhimurium. This highly repressible system allows us to extend the use of OprI vectors in other Gram (-) bacteria, resulting in the production of outer membrane-bound lipid-modified molecules, opening the possibility for its application in the design of potential live Salmonella-based subunit vaccines.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0378-1119(98)00437-5DOI Listing

Publication Analysis

Top Keywords

gram bacteria
12
membrane-bound opri
8
opri lipoprotein
8
expression vector
8
vector high
8
high production
8
fusion proteins
8
outer membrane-bound
8
production
5
lipoprotein expression
4

Similar Publications

The innate immune system plays a critical role in the rapid recognition and elimination of pathogens through pattern recognition receptors (PRRs). Among these PRRs are the C-type lectins (CTLs) langerin, mannan-binding lectin (MBL), and surfactant protein D (SP-D), which recognize carbohydrate patterns on pathogens. Each represents proteins from different compartments of the body and employs separate effector mechanisms.

View Article and Find Full Text PDF

Background: Bacterial infections in the Intensive Care Units are a threat to the lives of critically ill patients. Their vulnerable immunity predisposes them to developing bacteria-associated sepsis, deteriorating their already fragile health. In the face of increasing antibiotics resistance, the problem of bacterial infection in ICU is worsening.

View Article and Find Full Text PDF

Antibiotic-resistant Gram-negative bacteria are an increasing threat to human health. Strategies to restore antibiotic efficacy include targeting multidrug efflux pumps by competitive efflux pump inhibitors. These could be derived from natural substrates of these efflux systems.

View Article and Find Full Text PDF

Preparation and evaluation of MSR-1 bioinoculant on the growth and productivity of (L.) R. Wilczek.

3 Biotech

February 2025

Marine Biotechnology and Bioproducts Laboratory, Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, 632014 Tamil Nadu India.

Unlabelled: Recently, there has been a growing interest in the application of beneficial microorganisms to enhance crop performance.  (MSR-1) are spiral-shaped, gram-negative bacteria that exhibit magnetotaxis with the help of magnetosomes (iron oxide or iron sulphide). They have exhibited biomedical and environmental applications; however, the agricultural utilization of these strains is yet to be explored.

View Article and Find Full Text PDF

Extracellular vesicles (EVs) have garnered attention in research for their potential as biochemical transporters and immune modulators, crucial for regulating the host immune system. The present study was conducted to isolate and characterize EVs from Gram negative bacteria (EVs) and investigate their proteomic profile and immune responses. Isolation of EVs was carried out using ultracentrifugation method.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!